ICD-10 Coding for Testosterone Screening(E23.0, E23.0B, E23.0H)
Explore detailed guidelines for testosterone screening, including ICD-10 coding, documentation requirements, and common pitfalls.
Complete code families applicable to Testosterone Screening
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E29.1 | Testicular hypofunction | Use when primary hypogonadism is confirmed by lab tests and clinical symptoms. |
|
| E23.0 | Hypopituitarism | Use when hypogonadism is secondary to pituitary dysfunction. |
|
| E89.5 | Postprocedural hypogonadism | Use when hypogonadism occurs after a surgical procedure like orchiectomy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutTestosterone Screening
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Testosterone Screening.
Inadequate documentation of symptoms
Impact
Clinical: May lead to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials or reduced reimbursement.
Mitigation
Thoroughly document all patient-reported symptoms., Link symptoms to lab results in the medical record.
Using E34.9 for unspecified endocrine disorder
Impact
Reimbursement: May lead to claim denials due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Reduces accuracy of health data.
Mitigation
Use specific codes like E29.1 or E23.0 based on clinical findings.
Testosterone testing documentation
Impact
Inadequate documentation of lab results and symptoms.
Mitigation
Ensure all lab results and symptoms are clearly documented and linked.